CNSX:VYGR

Voyager Therapeutics Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive VYGR News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter.


About Voyager Therapeutics

Voyager Digital Ltd., through its subsidiaries, engages in the development and commercialization of a digital platform that enables users to buy and sell digital assets (cryptocurrencies) across multiple exchanges in one account primarily in the United States and Canada. The company was founded in 2018 and is headquartered in New York, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Voyager Therapeutics (CNSX:VYGR) Frequently Asked Questions

Is Voyager Therapeutics a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Voyager Therapeutics in the last twelve months. There are currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" Voyager Therapeutics stock.
View analyst ratings for Voyager Therapeutics
or view top-rated stocks.

What stocks does MarketBeat like better than Voyager Therapeutics?

Wall Street analysts have given Voyager Therapeutics a "Strong Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Voyager Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Voyager Therapeutics' key executives?

Voyager Therapeutics' management team includes the following people:
  • Mr. Philip Eytan, Co-Founder & Non-Exec. Independent Chairman (Age 44)
  • Mr. Stephen Ehrlich, Co-Founder, CEO & Director (Age 54)
  • Mr. Gaspard de Dreuzy, Co-Founder (Age 45)
  • Mr. Oscar Salazar, Co-Founder & Technical Advisor (Age 43)
  • Mr. Evan Psaropoulos, Chief Financial Officer
  • Mr. Gerard Hanshe, Chief Operating Officer (Age 44)
  • Mr. Daniel Costantino CISM, CISSP, Chief Information Security Officer
  • Ms. Janice Jones Barrilleaux, Chief Compliance Officer (Age 54)
  • Mr. David Brosgol, Gen. Counsel
  • Mr. Michael Frederick Legg Sr., Chief Communications Officer

Who are some of Voyager Therapeutics' key competitors?

What is Voyager Therapeutics' stock symbol?

Voyager Therapeutics trades on the CNSX under the ticker symbol "VYGR."

How do I buy shares of Voyager Therapeutics?

Shares of VYGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Voyager Therapeutics' official website?

The official website for Voyager Therapeutics is www.investvoyager.com.

How can I contact Voyager Therapeutics?

The company can be reached via phone at 212 547 8807.


This page was last updated on 7/29/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.